GSK scores FDA ap­proval for an­tibi­ot­ic to treat un­com­pli­cat­ed UTIs

GSK won ap­proval on Tues­day for a new type of oral an­tibi­ot­ic to treat un­com­pli­cat­ed uri­nary tract in­fec­tions.

The drug, called Blu­jepa or gepoti­dacin, will …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER